BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25341306)

  • 1. Clinical-epidemiological trends of herpes zoster: a 5-year study.
    Brănişteanu DE; Stoleriu G; Oanţă A; Dorobăţ CM; Petrariu FD; Anchidin DM; Ciubotaru FM; Brănişteanu DC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):817-22. PubMed ID: 25341306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the incidence and clinical manifestations of herpes zoster].
    Cerný Z
    Cas Lek Cesk; 1996 Apr; 135(8):244-8. PubMed ID: 8689663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes zoster in eastern Saudi Arabia: clinical presentation and management.
    Alakloby OM; AlJabre SH; Randhawa MA; Alzahrani AJ; AlWunais KM; Bukhari IA
    J Drugs Dermatol; 2008 May; 7(5):457-62. PubMed ID: 18505138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
    Wood SM; Shah SS; Steenhoff AP; Rutstein RM
    Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Herpes zoster in the Czech Republic--epidemiology and clinical manifestations].
    Smetana J; Salavec M; Bostíková V; Chlíbek R; Bostík P; Hanovcová I; Vacková M; Matulková P; Splino M
    Epidemiol Mikrobiol Imunol; 2010 Aug; 59(3):138-46. PubMed ID: 20925251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic venous disease cases at the Iaşi dermatology clinic.
    Stătescu L; Vâţă D; Andrese E; Solovăstru LG
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):1000-7. PubMed ID: 25581960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of herpes zoster and its painful and debilitating complications.
    Johnson R; McElhaney J; Pedalino B; Levin M
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Outcomes in a Population With Disseminated Herpes Zoster: A Retrospective Cohort Study.
    Bollea-Garlatti ML; Bollea-Garlatti LA; Vacas AS; Torre AC; Kowalczuk AM; Galimberti RL; Ferreyro BL
    Actas Dermosifiliogr; 2017 Mar; 108(2):145-152. PubMed ID: 27938930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic.
    Goh CL; Khoo L
    Int J Dermatol; 1997 Sep; 36(9):667-72. PubMed ID: 9352407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Varicella-zoster infection--extreme clinical aspects].
    Maniciuc C; Dorobaţ C; Hurmuzache M; Mihalache D; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):852-5. PubMed ID: 17438887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Herpes Zoster and its prevention in Italy. Scientific consensus statement].
    Franco E; Gabutti G; Bonanni P; Conversano M; Stefano Valente ME; Ferro A; Icardi G; Antonio Volpi ML; Maggi S; Rossi A; Scotti S; Vitale F; Greco D;
    Ig Sanita Pubbl; 2014; 70(1):111-27. PubMed ID: 24770367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program.
    Tanuseputro P; Zagorski B; Chan KJ; Kwong JC
    Vaccine; 2011 Nov; 29(47):8580-4. PubMed ID: 21939721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.
    Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF
    Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004.
    Pérez-Farinós N; Ordobás M; García-Fernández C; García-Comas L; Cañellas S; Rodero I; Gutiérrez-Rodríguez A; García-Gutiérrez J; Ramírez R
    BMC Infect Dis; 2007 Jun; 7():59. PubMed ID: 17570859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture.
    Toyama N; Shiraki K;
    J Med Virol; 2009 Dec; 81(12):2053-8. PubMed ID: 19856466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family history and herpes zoster risk in the era of shingles vaccination.
    Hernandez PO; Javed S; Mendoza N; Lapolla W; Hicks LD; Tyring SK
    J Clin Virol; 2011 Dec; 52(4):344-8. PubMed ID: 21924676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.